Edwards Lifesciences (EW) Net Income Growth (5y) (2014 - 2025)
Edwards Lifesciences (EW) Net Income Growth (5y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.60% |
| Sep 30, 2025 | -14.94% |
| Jun 30, 2025 | 48.54% |
| Mar 31, 2025 | -15.13% |
| Dec 31, 2024 | -32.49% |
| Sep 30, 2024 | 58.03% |
| Jun 30, 2024 | -66.65% |
| Mar 31, 2024 | -36.34% |
| Dec 31, 2023 | 39.21% |
| Sep 30, 2023 | -26.40% |
| Jun 30, 2023 | -28.16% |
| Mar 31, 2023 | -28.03% |
| Dec 31, 2022 | 136.26% |
| Sep 30, 2022 | 15.09% |
| Jun 30, 2022 | 16.91% |
| Mar 31, 2022 | 10.17% |
| Dec 31, 2021 | 16.17% |
| Sep 30, 2021 | 19.19% |
| Jun 30, 2021 | 31.06% |
| Mar 31, 2021 | 18.79% |